Central control of thermogenesis

Neuropharmacology

Volumn 63, Issue 1, 2012, Pages 111-123

  Clapham, John C ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Anti obesity agents; Central regulation; Hypothalamus; Obesity; Sympathetic nervous system; Thermogenesis

Indexed keywords

AMFEBUTAMONE; AMFEBUTAMONE PLUS NALTREXONE; ANTIOBESITY AGENT; DRINABANT; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR 1 ANTAGONIST; NALTREXONE; NEUROPEPTIDE; PHENTERMINE; PHENTERMINE PLUS TOPIRAMATE; PLACEBO; RIMONABANT; SEROTONIN 1A AGONIST; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE;

ADRENERGIC ACTIVITY; BARIATRIC SURGERY; BASAL METABOLIC RATE; BRAIN REGION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL EFFECTIVENESS; DEPRESSION; DIETARY INTAKE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENERGY EXPENDITURE; HUMAN; MOTONEURON; NERVE CELL NETWORK; NEUROANATOMY; NEUROMODULATION; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SHIVERING; SINGLE DRUG DOSE; TEMPERATURE ACCLIMATIZATION; TEMPERATURE SENSITIVITY; THERMOGENESIS; TREATMENT DURATION; WEIGHT REDUCTION;

ANIMALS; ANTI-OBESITY AGENTS; BRAIN; ENERGY METABOLISM; HUMANS; MOTOR ACTIVITY; SYMPATHETIC NERVOUS SYSTEM; THERMOGENESIS;

EID: 84862140556     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.10.014     Document Type: Review

References (176)

1. C. Addy, H. Wright, K. Van Laere, I. Gantz, N. Erondu, B.J. Musser, K. Lu, J. Yuan, S.M. Sanabria-Bohórquez, A. Stoch, C. Stevens, T.M. Fong, I. De Lepeleire, C. Cilissen, J. Cote, K. Rosko, I.N. Gendrano III, A. Nguyen, B. Gumbiner, P. Rothenberg, J. de Hoon, G. Bormans, M. Depré, W. Eng, E. Ravussin, S. Klein, J. Blundell, G.A. Herman, H.D. Burns, R.J. Hargreaves, J. Wagner, K. Gottesdiener, J.M. Amatruda, and S.B. Heymsfield The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake Cell Metab. 7 2008 68 78
2. J.W. Anderson, F.L. Greenway, K. Fujioka, K.M. Gadde, J. McKenney, and P.M. O'Neil Bupropion SR enhances weight loss: a 48-week double-blind, placebo-controlled trial Obes. Res. 10 2002 633 641
3. 3-adrenoceptor agonist drug development Ther. Adv. Endocrinol. Metab. 2 2011 39 64
4. J.R.S. Arch, D. Hislop, S.J.Y. Wang, and J.R. Speakman Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals Int. J. Obes. Relat. Metab. Disord. 30 2006 1322 1331
5. A. Astrand, Y. Bohlooly, S. Larsdotter, M. Mahlapuu, H. Andersen, J. Tornell, C. Ohlsson, M. Snaith, and D.G. Morgan Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 2004 R749 R758
6. A. Astrup, I. Caterson, P. Zelissen, B. Guy-Grand, M. Carruba, B. Levy, X. Sun, M. Fitchet, and for the OBES-004 study group Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects Obes. Res. 12 2004 1658 1669
7. A. Astrup, P.C. Gotzsche, K. van de Werken, C. Ranneries, S. Toubro, A. Raben, and B. Buemann Meta-analysis of resting metabolic rate in formerly obese subjects Am. J. Clin. Nutr. 69 1999 1117 1122
8. T.J. Bartness, and M. Bamshad Innervation of mammalian white adipose tissue: implications for the regulation of total body fat Am. J. Physiol. Regul. Integr. Comp. Physiol. 275 1998 R1399 R1411
9. T.J. Bartness, and C.K. Song Sympathetic and sensory innervation of white adipose tissue J. Lipid Res. 48 2007 1655 1672
10. S. Bátkai, P. Pacher, D. Osei-Hyiaman, S. Radaeva, J. Liu, J. Harvey-White, L. Offertáler, K. Mackie, M.A. Rudd, R.D. Bukoski, and G. Kunos Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension Circulation 110 2004 1996 2002
11. C.G. Bell, D. Meyre, C. Samson, C. Boyle, C. Lecoeur, M. Tauber, B. Jouret, D. Jaquet, C. Levy-Marchal, M.A. Charles, J. Weill, F. Gibson, C.A. Mein, P. Froguel, and A.J. Walley Association of melanin-concentrating hormone receptor 1 5' polymorphism with early-onset extreme obesity Diabetes 54 2005 3049 3055
12. M. Bensaid, M. Gary-Bobo, A. Esclangon, J.P. Maffrand, G. Le Fur, F. Oury-Donat, and P. Soubrie The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa Rats and in cultured adipocyte cells Mol. Pharmacol. 63 2003 908 914
13. S. Berglund, B.J. Egner, H. Graden, J. Graden, D.G. Morgan, T. Inghardt, and F. Giordanetto Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: designing out hERG inhibition Bioorg. Med. Chem. Lett. 19 2009 4268 4273
14. S. Berglund, B.J. Egner, H. Graden, J. Graden, D.G. Morgan, T. Inghardt, and F. Giordanetto Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: reducing hERG-associated liabilities Bioorg. Med. Chem. Lett. 19 2009 4274 4279
15. K.C. Bicego, R.C.H. Barros, and L.G.S. Branco Physiology of temperature regulation: comparative aspects Comp. Biochem. Physiol. A 147 2007 616 639
16. S.K. Billes, and M.A. Cowley Inhibition of dopamine and norepinephrine reuptake produces additive effects on energy balance in lean and obese mice Neuropsychopharmacol 32 2007 822 834
17. S.K. Billes, and M.A. Cowley Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis Neuropsychopharmacol 33 2008 1287 1297
18. J.C. Bittencourt, F. Presse, C. Arias, C. Peto, J. Vaughan, J.L. Nahon, W. Vale, and P.E. Sawchenko The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization J. Comp. Neurol. 319 1992 218 245
19. B. Borowsky, M.M. Durkin, K. Ogozalek, M.R. Marzabadi, J. DeLeon, B. Lagu, R. Heurich, H. Lichtblau, Z. Shaposhnik, I. Daniewska, T.P. Blackburn, T.A. Branchek, C. Gerald, P.J. Vaysse, and C. Forray Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist Nat. Med. 8 2002 825 830
20. H. Böttcher, and P. Fürst Decreased white fat cell thermogenesis in obese individuals Int. J. Obes. 21 1997 439 444
21. J.A. Boulant Role of the preoptic-anterior hypothalamus in thermoregulation and fever Clin. Infect. Dis. 31 2000 S157 S161
22. G.A. Bray Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications Int. J. Obes. Relat. Metab. Disord. 24 2000 S8 S17
23. G.A. Bray, P. Hollander, S. Klein, R. Kushner, B. Levy, M. Fitchet, and B.H. Perry A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity Obes. Res. 11 2003 722 733
24. G.A. Bray, D.H. Ryan, D. Gordon, S. Heidingsfelder, F. Cerise, and K. Wilson A double-blind randomized placebo-controlled trial of sibutramine Obes. Res. 4 1996 263 270
25. W.R. Buckett, P.C. Thomas, and G.P. Luscombe The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog Neuropsychopharmacol. Biol. Psychiatry 12 1988 575 584
26. R.M. Buijs, S.E. la Fleur, J. Wortel, C. Van Heyningen, L. Zuiddam, T.C. Mettenleiter, A. Kalsbeek, K. Nagai, and A. Niijima The suprachiasmatic nucleus balances sympathetic and parasympathetic output to peripheral organs through separate preautonomic neurons J. Comp. Neurol. 464 2003 36 48
27. P.J. Butler, J.A. Green, I.L. Boyd, and J.R. Speakman Measuring metabolic rate in the field: the pros and cons of the doubly labelled water and heart rate methods Funct. Ecol. 18 2004 168 183
28. B. Cannon, and J. Nedergaard Brown adipose tissue: function and physiological significance Physiol. Rev. 84 2004 277 359
29. B. Cannon, and J. Nedergaard Nonshivering thermogenesis and its adequate measurement in metabolic studies J. Exp. Biol. 214 2011 242 253
30. G. Cano, A.M. Passerin, J.C. Schiltz, J.P. Card, S.F. Morrison, and A.F. Sved Anatomical substrates for the central control of sympathetic outflow to interscapular adipose tissue during cold exposure J. Comp. Neurol. 460 2003 303 326
31. W.H. Cao, and S.F. Morrison Glutamate receptors in the raphe pallidus mediate brown adipose tissue thermogenesis evoked by activation of dorsomedial hypothalamic neurons Neuropharmacology 51 2006 426 437
32. J. Chambers, R.S. Ames, D. Bergsma, A. Muir, L.R. Fitzgerald, G. Hervieu, G.M. Dytko, J.J. Foleyk, J. Martin, W.S. Liu, J. Park, C. Ellis, S. Ganguly, S. Konchar, J. Cluderay, R. Leslie, S. Wilson, and H.M. Sarauk Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1 Nature 400 1999 261 265
33. X.M. Chen, T. Hosono, T. Yoda, Y. Fukuda, and K. Kanosue Efferent projection from the preoptic area for the control of non-shivering thermogenesis in rats J. Physiol. (Lond.) 512 1998 883 892
34. R. Christensen, P.K. Kristensen, E.M. Bartels, H. Bliddal, and A. Astrup Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials The Lancet 370 2007 1706 1713
35. L. Christin, M. O'Connell, C. Bogardus, E.J. Danforth, and E. Ravussin Norepinephrine turnover and energy expenditure in Pima Indian and white men Metabolism 42 1993 723 729
36. J.C. Clapham, and J.R.S. Arch Thermogenic and metabolic antiobesity drugs: rationale and opportunities Diabetes Obes. Metab. 9 2007 259 275
37. J.C. Clapham, and J.R.S. Arch Targeting thermogenesis and related pathways in anti-obesity drug discovery Pharmacol. Ther. 131 2011 295 308
38. J.C. Clapham, and L.H. Storlien The fatty acid oxidation pathway as a therapeutic target for insulin resistance Expert Opin. Therap. Targets 10 2006 749 757
39. I.P. Connoley, Y.L. Liu, I. Frost, I.P. Reckless, D.J. Heal, and M.J. Stock Thermogenic effects of sibutramine and its metabolites Br. J. Pharmacol. 126 1999 1487 1495
40. J.H. Coote Landmarks in understanding the central nervous control of the cardiovascular system Exp. Physiol. 92 2007 3 18
41. A.M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, A.B. Goldfine, F.C. Kuo, E.L. Palmer, Y.H. Tseng, A. Doria, G.M. Kolodny, and C.R. Kahn Identification and importance of brown adipose tissue in adult humans N. Engl. J. Med. 360 2009 1509 1517
42. A.A. da Silva, J. do Carmo, J. Dubinion, and J.E. Hall The role of the sympathetic nervous system in obesity-related hypertension Curr. Hypertens. Rep. 11 2009 206 211
43. K.P. Davy, and J.S. Orr Sympathetic nervous system behavior in human obesity Neurosci. Biobehav. Rev. 33 2009 116 124
44. C. Day, and C.J. Bailey Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice Int. J. Obes. Relat. Metab. Disord. 22 1998 619 623
45. B. De Luca, M. Monda, S. Amaro, M.P. Pellicano, and L.A. Cioffi Lack of diet-induced thermogenesis following lesions of paraventricular nucleus in rats Physiol. Behav. 46 1989 685 691
46. A. DelParigi, K. Chen, A.D. Salbe, J.O. Hill, R.R. Wing, E.M. Reiman, and P.A. Tataranni Persistence of abnormal neural responses to a meal in postobese individuals Int. J. Obes. Relat. Metab. Disord. 28 2004 370 377
47. A. DelParigi, N. Pannacciulli, D.N.T. Le, and P.A. Tataranni In pursuit of neural risk factors for weight gain in humans Neurobiol. Aging 26 2005 50 55
48. J.P. Després, A. Golay, and L. Sjöström Effects of rimonabant on metabolic risk Factors in overweight patients with dyslipidemia N. Engl. J. Med. 353 2005 2121 2134
49. J.A. DiMicco, and D.V. Zaretsky The dorsomedial hypothalamus: a new player in thermoregulation Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 2007 R47 R63
50. E. Doucet, P. Imbeault, N. Alméras, P. Mauriège, J.P. Després, C. Bouchard, and A. Tremblay Greater than predicted decrease in energy expenditure during exercise after body weight loss in obese men Clin. Sci. (Lond) 105 2003 89 95
51. C. Ekmekcioglu, and Y. Touitou Chronobiological aspects of food intake and metabolism and their relevance on energy balance and weight regulation Obes. Rev. 12 2011 14 25
52. B. Eliasson, S. Gudbjörnsdottir, J. Cederholm, Y. Liang, F. Vercruysse, and U. Smith Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial Int. J. Obes. Relat. Metab. Disord. 31 2007 1140 1147
53. N. Finer Sibutramine: its mode of action and efficacy Int. J. Obes. Relat. Metab. Disord. 26 2002 S29 S33
54. J.P. Fisher, C.N. Young, and P.J. Fadel Central sympathetic overactivity: maladies and mechanisms Auton. Neurosci. 148 2009 5 15
55. S. Fried, K. O'Neill, and B.E. Hawes Cloning and characterization of rhesus monkey MCH-R1 and MCH-R2 Peptides 23 2002 1401 1408
56. K.M. Gadde, D.B. Allison, D.H. Ryan, C.A. Peterson, B. Troupin, M.L. Schwiers, and W.W. Day Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial Lancet 377 2011 1341 1352
57. K.M. Gadde, C.B. Parker, L.G. Maner, H.R. Wagner, E.J. Logue, M.K. Drezner, and K.R. Krishnan Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women Obes. Res. 9 2001 544 551
58. N.R. Gavva Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1 Trends Pharmacol. Sci. 29 2008 550 557
59. N.R. Gavva, A.W. Bannon, S. Surapaneni, D.N. Hovland Jr., S.G. Lehto, A. Gore, T. Juan, H. Deng, B. Han, L. Klionsky, R. Kuang, A. Le, R. Tamir, J. Wang, B. Youngblood, D. Zhu, M.H. Norman, E. Magal, J.J. Treanor, and J.C. Louis The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation J. Neurosci. 27 2007 3366 3374
60. J.W. Gibbs, S. Sombati, R.J. DeLorenzo, and D.A. Coulter Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons Epilepsia 41 2000 S10 S16
61. W.T. Gibson, P. Pissios, D.J. Trombly, J. Luan, J. Keogh, N.J. Wareham, E. Maratos-Flier, S. O'Rahilly, and I.S. Farooqi Melanin-concentrating hormone receptor mutations and human obesity: functional analysis Obes. Res. 12 2004 743 749
62. C. Goldstein, J.C. Schroeder, J.P. Fortin, J.M. Goss, S.E. Schaus, M. Beinborn, and A.S. Kopin Two naturally occurring mutations in the type 1 melanin-concentrating hormone receptor abolish agonist-induced signaling J. Pharmacol. Exp. Ther. 335 2010 799 806
63. G. Grassi, R. Dell'Oro, A. Facchini, F. Quarti Trevano, G.B. Bolla, and G. Mancia Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives J. Hypertens. 22 2004 2363 2369
64. G. Grassi, G. Seravalle, M. Colombo, G. Bolla, B.M. Cattaneo, F. Cavagnini, and G. Mancia Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans Circulation 97 1998 2037 2042
65. F.L. Greenway, E. Dunayevich, G. Tollefson, J. Erickson, M. Guttadauria, K. Fujioka, M.A. Cowley, and G. Study Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo J. Clin. Endocrinol. Metab. 94 2009 4898 4906
66. R. Guerrini, and L. Parmeggiani Topiramate and its clinical applications in epilepsy Expert Opin. Pharmacother. 7 2006 811 823
67. N. Haddjeri, M. De, and P. Blier Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system Br. J. Pharmacol. 120 1997 865 875
68. C.K. Haddock, W.S. Poston, P.L. Dill, J.P. Foreyt, and M. Ericsson Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials Int. J. Obes. Relat. Metab. Disorders: J. Int. Assoc. for Study Obes. 26 2002 262 273
69. C. Haggerty, N. Hoggard, D.S. Brown, J.C. Clapham, and J.R. Speakman Intra-specific variation in resting metabolic rate in MF1 mice is not associated with membrane lipid desaturation in the liver Mech. Ageing Dev. 129 2008 129 137
70. D.L. Hansen, S. Toubro, M.J. Stock, I.A. Macdonald, and A. Astrup Thermogenic effects of sibutramine in humans Am. J. Clin. Nutr. 68 1998 1180 1186
71. H. Hasegawa, R. Meeusen, S. Sarre, M. Diltoer, M.F. Piacentini, and Y. Michotte Acute dopamine/norepinephrine reuptake inhibition increases brain and core temperature in rats J. Appl. Physiol. 99 2005 1397 1401
72. D.J. Heal, J. Gosden, and S.L. Smith Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders Br. J. Clin. Pharmacol. 68 2009 861 874
73. S. Henness, and C.M. Perry Orlistat: a review of its use in the management of obesity Drugs 66 2006 1625 1656
74. A.W. Herling, M. Gossel, G. Haschke, S. Stengelin, J. Kuhlmann, G. Muller, D. Schmoll, and W. Kramer CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats Am. J. Physiol. Endocrinol. Metab. 293 2007 E826 E832
75. A.W. Herling, S. Kilp, R. Elvert, G. Haschke, and W. Kramer Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats Endocrinology 149 2008 2557 2566
76. G.J. Hervieu, J.E. Cluderay, D. Harrison, J. Meakin, P. Maycox, S. Nasir, and R.A. Leslie The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat Eur. J. Neurosci. 12 2000 1194 1216
77. S.R. Hettes, W.J. Gonzaga, T.W. Heyming, J.K. Nguyen, S. Perez, and B.G. Stanley Stimulation of lateral hypothalamic AMPA receptors may induce feeding in rats Brain Res. 1346 2010 112 120
78. S.R. Hettes, T.W. Heyming, and B.G. Stanley Stimulation of lateral hypothalamic kainate receptors selectively elicits feeding behavior Brain Res. 1184 2007 178 185
79. J. Hirsch, R.M. Mackintosh, and L.J. Aronne The effects of drugs used to treat obesity on the autonomic nervous system Obes. Res. 8 2000 227 233
80. S. Hjörth Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT J. Neural Transm. 61 1985 131 135
81. P. Hollander Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus Am. J. Med. 120 2007 S18 S28
82. C.Q. Huang, T. Baker, D. Schwarz, J. Fan, C.E. Heise, M. Zhang, V.S. Goodfellow, S. Markison, K.R. Gogas, T. Chen, X.C. Wang, and Y.F. Zhu 1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)- pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists Bioorg. Med. Chem. Lett. 15 2005 3701 3706
83. M. Ito, A. Ishihara, A. Gomori, H. Matsushita, M. Ito, J.M. Metzger, D.J. Marsh, Y. Haga, H. Iwaasa, S. Tokita, N. Takenaga, N. Sato, D.J. MacNeil, M. Moriya, and A. Kanatani Mechanism of the anti-obesity effects induced by a novel melanin-concentrating hormone 1-receptor antagonist in mice Br. J. Pharmacol. 159 2010 374 383
84. H.C. Jackson, M.C.H. Bearham, S.E. Mazurkiewicz, A.M. Needham, and D.J. Heal Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat Br. J. Pharmacol. 121 1997 1613 1618
85. S.L. Johnston, D.M. Souter, B.J. Tolkamp, I.J. Gordon, A.W. Illius, I. Kyriazakis, and J.R. Speakman Intake compensates for resting metabolic rate variation in female C57BL/6J mice fed high-fat diets Obesity 15 2007 600 606
86. A.M. Johnstone, S.D. Murison, J.S. Duncan, K.A. Rance, and J.R. Speakman Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine Am. J. Clin. Nutr. 82 2005 941 948
87. R.T. Jung, P. Leslie, D.G. Nicholls, S. Cunningham, and T.E. Isles Energy expenditure in normal and diabetic man: the role of brown adipose tissue Health Bull. 46 1988 55 62
88. H. Kawasaki, V. Tancredi, G. Darcangelo, and M. Avoli Multiple actions of the novel anticonvulsant drug topiramate in the rat subiculum in vitro Brain Res. 807 1998 125 134
89. J. Kela, P. Salmi, R. Rimondini-Giorgini, M. Heilig, and C. Wahlestedt Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties Regul. Pept. 114 2003 109 114
90. E. Kokkotou, J.Y. Jeon, X. Wang, F.E. Marino, M. Carlson, D.J. Trombly, and E. Maratos-Flier Mice with MCH ablation resist diet-induced obesity through strain-specific mechanisms Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 2005 R117 R124
91. C.M. Kotz, J.A. Teske, and C.J. Billington Neuroregulation of nonexercise activity thermogenesis and obesity resistance Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 2008 R699 R710
92. T.J. Kowalski, C. Farley, M.E. Cohen-Williams, G. Varty, and B.D. Spar Melanin-concentrating hormone-1 receptor antagonism decreases feeding by reducing meal size Eur. J. Pharmacol. 497 2004 41 47
93. T.J. Kowalski, B.D. Spar, B. Weig, C. Farley, J. Cook, L. Ghibaudi, S. Fried, K. O'Neill, R.A. Del Vecchio, M. McBriar, H. Guzik, J. Clader, B.E. Hawes, and J. Hwa Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice Eur. J. Pharmacol. 535 2006 182 191
94. C.K. Kramer, C.B. Leitão, L.C. Pinto, L.H. Canani, M.J. Azevedo, and J.L. Gross Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials Obes. Rev. 12 2011 e338 e347
95. I. Kunz, M.K. Meier, A. Bourson, M. Fisseha, and W. Schilling Effects of rimonabant, a cannabinoid CB1 receptor ligand, on energy expenditure in lean rats Int. J. Obes. Relat. Metab. Disord. 32 2008 863 870
96. M. Lafontan, P.V. Piazza, and J. Girard Effects of CB1 antagonist on the control of metabolic functions in obese type 2 diabetic patients Diabetes Metab. 33 2007 85 95
97. E. Lambert, N. Straznicky, M. Schlaich, M. Esler, T. Dawood, E. Hotchkin, and G. Lambert Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension Hypertension 50 2007 862 868
98. G.W. Lambert, N.E. Straznicky, E.A. Lambert, J.B. Dixon, and M.P. Schlaich Sympathetic nervous activation in obesity and the metabolic syndrome: causes, consequences and therapeutic implications Pharmacol. Ther. 126 2010 159 172
99. L. Landsberg, J.B. Young, W.R. Leonard, R.A. Linsenmeier, and F.W. Turek Is obesity associated with lower body temperatures? Core temperature: a forgotten variable in energy balance Metabolism 58 2009 871 876
100. M. Lazarus The differential role of prostaglandin E2 receptors EP3 and EP4 in regulation of fever Mol. Nutr. Food Res. 50 2006 451 455
101. M.E. Lean Brown adipose tissue in humans Proc. Nutr. Soc. 48 1989 243 256
102. M.W. Lee, and K. Fujioka Naltrexone for the treatment of obesity: review and update Expert Opin. Pharmacother 10 2009 1841 1845
103. R.L. Leibel, M. Rosenbaum, and J. Hirsch Changes in energy expenditure resulting from altered body weight N. Engl. J. Med. 332 1995 621 628
104. J.A. Levine Measurement of energy expenditure Public Health Nutr. 8 2005 1123 1132
105. J.A. Levine, N.L. Eberhardt, and M.D. Jensen Role of nonexercise activity thermogenesis in resistance to fat gain in humans Science 283 1999 212 214
106. Y. Liang, X. Chen, M. Osborne, S.O. DeCarlo, T.L. Jetton, and K. Demarest Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice Diabetes Obes. Metab. 7 2005 360 369
107. Y.L. Liu, I.P. Connoley, D.J. Heal, and M.J. Stock Pharmacological characterisation of the thermogenic effect of bupropion Eur. J. Pharmacol. 498 2004 219 225
108. D.S. Ludwig, K.G. Mountjoy, J.B. Tatro, J.A. Gillette, R.C. Frederich, J.S. Flier, and E. Maratos-Flier Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus Am. J. Physiol. 274 1998 E627 E633
109. D.S. Ludwig, N.A. Tritos, J.W. Mastaitis, R. Kulkarni, E. Kokkotou, J. Elmquist, B. Lowell, J.S. Flier, and E. Maratos-Flier Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance J. Clin. Invest. 107 2001 379 386
110. G.C. Major, E. Doucet, P. Trayhurn, A. Astrup, and A. Tremblay Clinical significance of adaptive thermogenesis Int. J. Obes. Relat. Metab. Disord. 31 2006 204 212
111. D.J. Marsh, D.T. Weingarth, D.E. Novi, H.Y. Chen, M.E. Trumbauer, A.S. Chen, X.M. Guan, M.M. Jiang, Y. Feng, R.E. Camacho, Z. Shen, E.G. Frazier, H. Yu, J.M. Metzger, S.J. Kuca, L.P. Shearman, S. Gopal-Truter, D.J. MacNeil, A.M. Strack, D.E. MacIntyre, L.H. Van der Ploeg, and S. Qian Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism Proc. Natl. Acad. Sci. U S A 99 2002 3240 3245
112. G. Marsicano, and B. Lutz Neuromodulatory functions of the endocannabinoid system J. Endocrinol. Invest. 29 2006 27 46
113. T. Masaki, S. Chiba, T. Yasuda, T. Tsubone, T. Kakuma, I. Shimomura, T. Funahashi, Y. Matsuzawa, and H. Yoshimatsu Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice Diabetes 52 2003 2266 2273
114. D.D. McCoy, W.M. Knowlton, and D.D. McKemy Scraping through the ice: uncovering the role of TRPM8 in cold transduction Am. J. Physiol. Regul. Integr. Comp. Physiol. 300 2011 R1278 R1287
115. J.A. McLean, and G. Tobin Animal and Human Calorimetry first ed. 1987 Cambridge University Press Cambridge
116. J.L. Méndez-Andino, and J.A. Wos MCH-R1 antagonists: what is keeping most research programs away from the clinic? Drug Discov. Today 12 2007 972 979
117. M.M. Messina, and J.M. Overton Cardiovascular effects of melanin-concentrating hormone Regul. Pept. 139 2007 23 30
118. M.J. Millan, J.M. Rivet, H. Canton, S. Le Marouille-Girardon, and A. Gobert Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists J. Pharmacol. Exp. Ther. 264 1993 1364 1376
119. 2-adrenoceptors J. Pharmacol. Exp. Ther. 333 2010 445 453
120. M.E. Monzon, and S.R. De Barioglio Response to novelty after i.c.v. injection of melanin-concentrating hormone (MCH) in rats Physiol. Behav. 67 1999 813 817
121. S.F. Morrison Differential regulation of sympathetic outflows to vasoconstrictor and thermoregulatory effectors Ann. N. Y. Acad. Sci. 940 2001 286 298
122. S.F. Morrison, and K. Nakamura Central neural pathways for thermoregulation Front. Biosci. 16 2011 74 104
123. S.F. Morrison, K. Nakamura, and C.J. Madden Central control of thermogenesis in mammals Exp. Physiol. 93 2008 773 797
124. S.G. Nair, T. Adams-Deutsch, C.L. Pickens, D.G. Smith, and Y. Shaham Effects of the MCH1 receptor antagonist SNAP 94847 on high-fat food-reinforced operant responding and reinstatement of food seeking in rats Psychopharmacology 205 2009 129 140
125. K. Nakamura, K. Matsumura, T. Hübschle, Y. Nakamura, H. Hioki, F. Fujiyama, Z. Boldogköi, M. König, H.J. Thiel, R. Gerstberger, S. Kobayashi, and T. Kaneko Identification of sympathetic premotor neurons in medullary raphe regions mediating fever and other thermoregulatory functions J. Neurosci. 24 2004 5370 5380
126. K. Nakamura, and S.F. Morrison A thermosensory pathway that controls body temperature Nat. Neurosci. 11 2008 62 71
127. J. Nedergaard, T. Bengtsson, and B. Cannon Unexpected evidence for active brown adipose tissue in adult humans Am. J. Physiol. Endocrinol. Metab. 293 2007 E444 E452
128. N. Niederhoffer, K. Schmid, and B. Szabo The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression Naunyn-Schmiedeberg's Arch. Pharmacol. 367 2003 434 443
129. R. Nogueiras, C. Veyrat-Durebex, P.M. Suchanek, M. Klein, J. Tschöp, C. Caldwell, S.C. Woods, G. Wittmann, M. Watanabe, Z. Liposits, C. Fekete, O. Reizes, F. Rohner-Jeanrenaud, and M.H. Tschöp Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats Diabetes 57 2008 2977 2991
130. R. Padwal, S. Klarenbach, N. Wiebe, D. Birch, S. Karmali, B. Manns, M. Hazel, A.M. Sharma, and M. Tonelli Bariatric surgery: a systematic review and network meta-analysis of randomized trials Obes. Rev. 12 2011 602 621
131. A. Patapoutian, A.M. Peier, G.M. Story, and V. Viswanath Thermo TRP channels and beyond: mechanisms of temperature sensation Nat. Rev. Neurosci. 2003 529 539
132. J. Picot, J. Jones, J.L. Colquitt, E. Gospodarevskaya, E. Loveman, L. Baxter, and A.J. Clegg The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation Health Technol. Assess. 13 2009 1 190
133. D. Purves, G.J. Augustine, D. Fitzpatrick, W.C. Hall, A.S. LaMantia, and L.E. White Central nervous system dimorphisms related to reproductive behaviour Neuroscience second ed. 2001 Figure 30.5. Sinauer Associates Sunderland MA.
134. C. Quarta, L. Bellocchio, G. Mancini, R. Mazza, C. Cervino, L.J. Braulke, C. Fekete, R. Latorre, C. Nanni, M. Bucci, L.E. Clemens, G. Heldmaier, M. Watanabe, T. Leste-Lassere, M. Maitre, L. Tedesco, F. Fanelli, S. Reuss, S. Klaus, R.K. Srivastava, K. Monory, A. Valerio, A. Grandis, R. De Giorgio, R. Pasquali, E. Nisoli, D. Cota, B. Lutz, G. Marsicano, and U. Pagotto CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance Cell Metab. 11 2010 273 285
135. E. Ravussin, S. Lillioja, T.E. Anderson, L. Christin, and C. Bogardus Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber J. Clin. Invest. 78 1986 1568 1578
136. E. Ravussin, S. Lillioja, W.C. Knowler, L. Christin, D. Freymond, W.G. Abbott, V. Boyce, B.V. Howard, and C. Bogardus Reduced rate of energy expenditure as a risk factor for body-weight gain N. Engl. J. Med. 318 1988 467 472
137. E. Ravussin, and P.A. Tataranni The role of altered sympathetic nervous system activity in the pathogenesis of obesity Proc. Nutr. Soc. 55 1996 793 802
138. M. Rosenbaum, and R.L. Leibel Adaptive thermogenesis in humans Int. J. Obes. 34 2010 S47 S55
139. M. Rossi, S.J. Choi, D. O'Shea, T. Miyoshi, M.A. Ghatei, and S.R. Bloom Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight Endocrinology 138 1997 351 355
140. N.J. Rothwell, and M.J. Stock Luxuskonsumption, diet-induced thermogenesis and brown fat: the case in favour Clin. Sci. (Lond) 64 1983 19 23
141. N.J. Rothwell, M.J. Stock, and A.J. Thexton Decerebration activates thermogenesis in the rat J. Physiol. 342 1983 15 22
142. L.M. Ruilope, J.P. Despres, A. Scheen, X. PiSunyer, G. Mancia, A. Zanchetti, and L. Van Gaal Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results J. Hypertens. 26 2008 357 367
143. J. Rutanen, J. Pihlajamäki, M. Vänttinen, U. Salmenniemi, E. Ruotsalainen, T. Kuulasmaa, S. Kainulainen, J. Kuusisto, and M. Laakso Single nucleotide polymorphisms of the MCHR1 gene do not affect metabolism in humans Obesity 15 2007 2902 2907
144. M. Saito, Y. Okamatsu-Ogura, M. Matsushita, K. Watanabe, T. Yoneshiro, J. Nio-Kobayashi, T. Iwanaga, M. Miyagawa, T. Kameya, K. Nakada, Y. Kawai, and M. Tsujisaki High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity Diabetes 58 2009 1526 1531
145. Y. Saito, M. Cheng, F.M. Leslie, and O. Civelli Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain J. Comp. Neurol. 435 2001 26 40
146. F. Sarac, M. Pehlivan, G. Celebi, F. Saygili, C. Yilmaz, and T. Kabalak Effects of sibutramine on thermogenesis in obese patients assessed via immersion calorimetry Adv. Ther. 23 2006 1016 1029
147. A. Sayburn Withdrawal of sibutramine leaves European doctors with just one obesity drug Brit. Med. J. 340 2010
148. A.J. Scheen CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant J. Neuroendocrinol 20 2008 139 146
149. R.S. Schwartz, L.F. Jaeger, and R.C. Veith Effect of clonidine on the thermic effect of feeding in humans Am. J. Physiol. Regul. Integr. Comp. Physiol. 254 1988 R90 R94
150. L.P. Shearman, R.E. Camacho, S.D. Sloan, D. Zhou, M.A. Bednarek, D.L. Hreniuk, S.D. Feighner, C.P. Tan, A.D. Howard, and L.H.T. Van der Ploeg Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats Eur. J. Pharmacol. 475 2003 37 47
151. M. Shimada, N.A. Tritos, B.B. Lowell, J.S. Flier, and E. Maratos-Flier Mice lacking melanin-concentrating hormone are hypophagic and lean Nature 396 1998 670 674
152. J.E. Silva Thermogenic mechanisms and their hormonal regulation Physiol. Rev. 86 2006 435 464
153. G. Skofitsch, D.M. Jacobowitz, and N. Zamir Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain Brain Res. Bull. 15 1985 635 649
154. C.J. Small, Y.L. Liu, S.A. Stanley, I.P. Connoley, A. Kennedy, M.J. Stock, and S.R. Bloom Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure Int. J. Obes. Relat. Metab. Disord. 27 2003 530 533
155. M. Spraul, E. Ravussin, A.M. Fontvieille, R. Rising, D.E. Larson, and E.A. Anderson Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain J. Clin. Invest. 92 1993 1730 1735
156. G.M. Story, A.M. Peier, A.J. Reeve, S.R. Eid, J. Mosbacher, T.R. Hricik, T.J. Earley, A.C. Hergarden, D.A. Andersson, S.W. Hwang, P. McIntyre, T. Jegla, S. Bevan, and A. Patapoutian ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures Cell 112 2003 819 829
157. T.R. Stratford, and A.E. Kelley GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior J. Neurosci. 17 1997 4434 4440
158. N.E. Straznicky, E.A. Lambert, G.W. Lambert, K. Masuo, M.D. Esler, and P.J. Nestel Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome J. Clin. Endocrinol. Metab. 90 2005 5998 6005
159. M. Szekely, E. Petervari, and M. Balasko Thermoregulation, energy balance, regulatory peptides: recent developments Front. Biosci. 2 2010 1009 1046
160. C.P. Tan, H. Sano, H. Iwaasa, J. Pan, A.W. Sailer, D.L. Hreniuk, S.D. Feighner, O.C. Palyha, S.S. Pong, and D.J. Figueroa Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression Genomics 79 2002 785 792
161. L. Tappy Thermic effect of food and sympathetic nervous system activity in humans Reprod. Nutr. Dev. 36 1996 391 397
162. J.A. Teske, C.J. Billington, and C.M. Kotz Neuropeptidergic mediators of spontaneous physical activity and non-exercise activity thermogenesis Neuroendocrinology 87 2008 71 90
163. G.H. Thomas, A.J. Babbs, R.E. Chatfield, T.M. Krulle, P.S. Widdowson, D. Provost, and J.G. McCormack 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats Obesity 17 2009 467 473
164. A.N. Verty, A.M. Allen, and B.J. Oldfield The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure Obesity 17 2008 254 261
165. A.N. Verty, A.M. Allen, and B.J. Oldfield The endogenous actions of hypothalamic peptides on brown adipose tissue thermogenesis in the rat Endocrinology 151 2010 4236 4246
166. C.R. Vianna, and R. Coppari A treasure trove of hypothalamic neurocircuitries governing body weight homeostasis Endocrinology 152 2011 11 18
167. J. Vidal Updated review on the benefits of weight loss Int. J. Obes. 26 2002 S25 S28
168. J. Webber, and I.A. Macdonald Signalling in body-weight homeostasis: neuroendocrine efferent signals Proc. Nutr. Soc. 59 2000 397 404
169. R.L. Weinsier, Y. Schutz, and D. Bracco Reexamination of the relationship of resting metabolic rate to fat-free mass and to the metabolically active components of fat-free mass in humans Am. J. Clin. Nutr. 55 1992 790 794
170. K. Westerterp Diet induced thermogenesis Nutr. Metab. 1 2004 1 5
171. C. Weyer, S. Snitker, C. Bogardus, and E. Ravussin Energy metabolism in African Americans: potential risk factors for obesity Am. J. Clin. Nutr. 70 1999 13 20
172. C. Weyer, S. Snitker, R. Rising, C. Bogardus, and E. Ravussin Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects Int. J. Obes. Relat. Metab. Disord. 23 1999 715 722
173. H.S. White, S.D. Brown, J.H. Woodhead, G.A. Skeen, and H.H. Wolf Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold Epilepsy Res. 28 1997 167 179
174. K. Wynne, A.J. Park, C.J. Small, K. Meeran, M.A. Ghatei, G.S. Frost, and S.R. Bloom Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial Int. J. Obes. Relat. Metab. Disord. 30 2006 1729 1736
175. J.B. Young, and I.A. Macdonald Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980 Int. J. Obes. Relat. Metab. Disord. 16 1992 959 967
176. W. Zhao, O. Fong, E.S. Muise, J.R. Thompson, D. Weingarth, S. Qian, and T.M. Fong Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters Mol. Pharmacol. 78 2010 350 359